Meso-tetra(hydroxyphenyl)chlorin: an in vivo photodegradation study

Avigdor M. Ronn; Lennart A. Lofgren M.D.

doi:10.1117/12.179973

19 July 1994 Meso-tetra(hydroxyphenyl)chlorin: an in vivo photodegradation study

Avigdor M. Ronn, Lennart A. Lofgren M.D.

Proceedings Volume 2133, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III; (1994) https://doi.org/10.1117/12.179973
Event: OE/LASE '94, 1994, Los Angeles, CA, United States

Abstract

This in vivo study was carried out to determine to what extent meso-tetra(hydroxyphenyl)chlorin (mTHPC), a chemically very stable second generation photosensitizer, can be 'photobleached'. Experiments were designed to determine if the degradation was dependent on the light dose and if clearance of drug could be achieved in an exposed skin area after a single exposure. Rabbits were injected with 0.3 mg/kg mTHPC and, utilizing injection to exposure intervals of 2 and 6 days, multiple skin areas were exposed to nonhyperthermic light at the absorption maximum (652 mn) for this drug. The exposed areas and control areas were excised immediately (or after an interval) and analyzed for drug content by chemical extraction and spectrofluorometry. Blood was taken prior to and again immediately after light exposure (or after 4 hours) to determine the drug levels circulating in the plasma. The drug content in skin could be reduced by half using light doses of 10 to 320 J/cm² independently of the fluence. Our findings indicate that 'bleaching' is dependent on the drug concentration in plasma. The concept of intentional 'bleaching' designed to reduce skin photosensitivity either prior to or after treatment is discussed with respect to these findings.

Citation Download Citation

Avigdor M. Ronn and Lennart A. Lofgren M.D. "Meso-tetra(hydroxyphenyl)chlorin: an in vivo photodegradation study", Proc. SPIE 2133, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy III, (19 July 1994); https://doi.org/10.1117/12.179973

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available